Post-approval studies (Phase 4)Study completedNCT03023683What this trial is testingProtective Mechanisms Against a Pandemic Respiratory Virus (SLVP024)Who this might be right forInfluenza Stanford University 18
Post-approval studies (Phase 4)Study completedNCT05499351What this trial is testingBooster Immunization With COVID-19 Vaccine,Inactivated Co -Administration With Influenza Vaccine and Pneumococcal Polysaccharide VaccineWho this might be right forCOVID-19 Sinovac Biotech Co., Ltd 3,000
Early research (Phase 1)Study completedNCT03898986What this trial is testingThe Effects of Attenuated Versus Inactivated Flu Vaccine in Twin SetsWho this might be right forInfluenza Stanford University 18
Not applicableStudy completedNCT02898688What this trial is testingP3+ Intervention PhaseWho this might be right forVaccination Emory University 2,200
Large-scale testing (Phase 3)Study completedNCT02103023What this trial is testingIntradermal Influenza Vaccine in the YoungWho this might be right forInfluenza Viral Infections The University of Hong Kong 160
Not applicableUnknownNCT03228095What this trial is testingVolatiles in Breath and Headspace Analysis - Diagnostic MarkersWho this might be right forTuberculosisGastric CancerPeptic Ulcer+13 more University of Latvia 3,000
Large-scale testing (Phase 3)Study completedNCT00970177What this trial is testingImmunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects 18 or More Years of AgeWho this might be right forPandemic Influenza Novartis Vaccines 812
Testing effectiveness (Phase 2)Study completedNCT01146119What this trial is testingFurther Investigation of an Intramuscular Influenza Vaccine (Multimeric-001)Who this might be right forInfluenza BiondVax Pharmaceuticals ltd. 200
Testing effectiveness (Phase 2)Study completedNCT00992212What this trial is testingImmunogenicity, Tolerability and Safety of One or Two Doses of an Adjuvanted Swine-origin A H1N1 Influenza Vaccine in Healthy Subjects 18 or More Years of Age Both Vaccinated and Not Yet Vaccinated Against Seasonal Influenza 2009/10Who this might be right forPandemic Influenza Disease Novartis Vaccines 418
Large-scale testing (Phase 3)Study completedNCT00616928What this trial is testingImmunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 YearsWho this might be right forInfluenza GlaxoSmithKline 4,561
Not applicableStudy completedNCT03599739What this trial is testingAdjuvanted Influenza Vaccination Year 2 Follow-On SurveyWho this might be right forInfluenzaInfluenza-like IllnessInfluenza, Human Insight Therapeutics, LLC 598
Testing effectiveness (Phase 2)Study completedNCT02436928What this trial is testingEvaluate the Safety and Immunogenicity of H7N9 Influenza Vaccine (AT-501) in Healthy Adult SubjectsWho this might be right forH7N9 Influenza Vaccine Medigen Vaccine Biologics Corp. 200
Not applicableStudy completedNCT02478905What this trial is testingTransmission of Influenza Virus From Asymptomatic Healthcare Workers and Inpatients in the Acute Care Hospital SettingWho this might be right forHuman Influenza University of Zurich 700
Large-scale testing (Phase 3)Study completedNCT01249183What this trial is testingSafety and Immunogenicity Study of Concomitant Versus Non Concomitant Administration of a Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine (REPEVAX) and Influenza Vaccine (VAXIGRIP) in Subjects Aged From 60 Years OldWho this might be right forDiphtheriaTetanusPertussis+1 more Sanofi Pasteur, a Sanofi Company 954
Early research (Phase 1)Study completedNCT02126761What this trial is testingSafety and Immunogenicity of Different Formulations of an Adjuvanted, Trivalent Subunit Influenza Vaccine in Elderly Subjects 65 Years of Age and AboveWho this might be right forInfluenza Seqirus 196
Post-approval studies (Phase 4)Study completedNCT02124161What this trial is testingConcomitant Administration of 13-valent Pneumococcal Conjugate Vaccine (13vPnC) With Influenza Vaccine in 23-valent Pneumococcal Polysaccharide (23vPS) Pre-vaccinated Adults.Who this might be right forPREVENTION OF INVASIVE PNEUMOCOCCAL DISEASE Pfizer 882
Not applicableStudy completedNCT01737710What this trial is testingAtopic Dermatitis Research Network (ADRN) Influenza Vaccine StudyWho this might be right forDermatitis, Atopic National Institute of Allergy and Infectious Diseases (NIAID) 368
Not applicableNot Yet RecruitingNCT07352462What this trial is testingVolatile Organic Compounds Analysis by GC-MS for Diagnostic of Hospitalised Patients With Respiratory Infections Using Exhaled BreathWho this might be right forRespiratory InfectionsCOVID-19Influenza Virus Infection+1 more Hospices Civils de Lyon 777
Not applicableStudy completedNCT06052527What this trial is testingCovid-19, Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) and Influenza Treatment System With Machine LearningWho this might be right forCOVID-19Post-COVID-19 SyndromeInfluenza Lizora LLC 27
Not applicableStudy completedNCT01416597What this trial is testingA Systematic Review of Studies of the Effect of Influenza Vaccine Against Mismatched StrainsWho this might be right forInfluenza GlaxoSmithKline 1